204 related articles for article (PubMed ID: 6285119)
1. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Pulverer G; Peters G
Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
[No Abstract] [Full Text] [Related]
2. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
3. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
4. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Neu HC; Labthavikul P
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
[No Abstract] [Full Text] [Related]
5. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
6. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria.
Preston DA
Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Trager GM; White GW; Zimelis VM; Bryk DA; Panwalker AP
Chemotherapy; 1981; 27(1):34-8. PubMed ID: 6260435
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Lang SD; Durack DT
Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
[No Abstract] [Full Text] [Related]
10. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
[TBL] [Abstract][Full Text] [Related]
11. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
12. [Statistical regression analysis for four new cephalosporins (author's transl)].
Sirot D; Glanddier Y; Chanal M; Sirot J; Cluzel R
Pathol Biol (Paris); 1982 Jun; 30(6):357-62. PubMed ID: 6287389
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Greenfield RA; Kurzynski TA; Craig WA
Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Woolfrey BF; Fox JM; Quall CO
J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
[No Abstract] [Full Text] [Related]
16. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
Vuye A
Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
Fitzpatrick BJ; Standiford HC
Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
